SYNBIOTIC SE |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.5 EUR | +4.17% |
|
-6.40% | +217.73% |
| Apr. 23 | SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover | MT |
| Apr. 23 | SynBiotic SE acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge. | CI |
Evolution of the average Target Price on SynBiotic SE
Price target over the last 5 years
History of analyst recommendation changes
7f5c735c8968bc.zcT19vXAnkf6nQRAfqPeBLWvvucKHZ91f7Mrkcnc6Zc.u67E277t9CzP-GpwCZSSPfHb24A7V81BS_Ea4b-R0OaSnJivxrOvArXySQ~00f34cb77bb3199b449e536c3b2d24b9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.5
EUR
Average target price
15.2
EUR
Spread / Average Target
+60.00%
High Price Target
15.2
EUR
Spread / Highest target
+60.00%
Low Price Target
15.2
EUR
Spread / Lowest Target
+60.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- SBX Stock
- Consensus SynBiotic SE
